This federal contract award, valued at $141,313.00, was issued by the Department of the Navy Bureau of Medicine and Surgery (BUMED) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for the provision of a NovaSeq 6000 Silver Support Plan, which includes maintenance and support services for this critical laboratory equipment used by the Naval Medical Research Command (NMRC) for mission-critical sequencing capabilities.
The contract was awarded on a sole source basis, as Illumina is the original equipment manufacturer for the NovaSeq 6000 system. It was procured under commercial item procedures, with no set-aside designation. This award is associated with an Indefinite Delivery Contract (IDC) worth up to $3.3 million that Illumina holds with BUMED to support the Navy's nucleic acid sequencing needs across various sequencing platforms.
Generated 3/7/25, 10:09 AM